definiens: means technology ( and the Patents that Cover such technology ) related to anything other than the manner in which Adimab c onstructed its antibody libraries, the manner in which Adimab discovers and/or optimizes the antibody, the Adimab Platform Technology, or its operation generally . Excluded Technology includes : ( a ) product formulation ; ( b ) manufacturing or production ; ( c ) the sequence of the CDRs of, or any modification to, a Program Antibody * * * ; ( d ) technology used in activities performed by or on behalf of Black Belt or its Licensees, including assays, in vivo testing, and modifications to Program Antibodies ; ( e ) any Target ( including the Black Belt Target and CD38 ) or any mechanism of action via interaction with a Target or claiming antibodies based on their interaction with a Target or their having been t ested for their activity against a Target in a biological assay ; and - 2 - ( f ) any particular Bispecific construct, but excluding any antibody framework common in Adimab ’s antibody library(ies )